| Application no. and date | 20728590.9 (espacenet) (Federated) (European Patent Register), 20200430 | | Patent/reg. no. and date | DK/EP 3962942, 20251022 | | Publication date | 20220309 | | Priority no. and date | US 201962841662 P, 20190501, EP 19181345, 20190619 | | EP pub. no. and date |
EP 3962942 20220309 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | ZHU, Gaozhong, Novo Nordisk A/S
Novo Alle, 2880 Bagsværd, DK,
SHAHROKH, Zahra, Novo Nordisk A/S
Novo Alle, 2880 Bagsværd, DK,
MELVILLE, Mark, Novo Nordisk A/S
Novo Alle, 2880 Bagsværd, DK,
DEVALARAJA, Madhav, N., Novo Nordisk A/S
Novo Alle, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , C07K 16/24 (2006.01) | | Title | ANTI-IL-6 ANTIBODY FORMULATION | | Int. application no. | US2020030865 | | Int. publication no. | WO2020223565 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
